• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. EQUINOXE; EQUINOXE REVERSE 38MM HUMERAL LINER +0

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. EQUINOXE; EQUINOXE REVERSE 38MM HUMERAL LINER +0 Back to Search Results
Model Number 320-38-00
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problems Bacterial Infection (1735); Unspecified Infection (1930)
Event Date 05/14/2019
Event Type  Injury  
Manufacturer Narrative
Pending evaluation.
 
Event Description
It was reported that a patient had a tsa on (b)(6) 2018.Revision occurred due to infection.
 
Event Description
It was reported that 1 month postoperatively from a tka, the patient¿s tibial insert was revised due to infection.It was also reported the patient was stable upon leaving the operation room.
 
Manufacturer Narrative
H10: (h3) it was reported that 1 month postoperatively from a tka, the patient¿s tibial insert was revised due to infection.It was also reported the patient was stable upon leaving the or.The sterile certificates from production of the tibial insert were reviewed and product meets customer specifications; zero nonconformities occurred during this irradiation run.Per ifu# 700-096-004, postoperative counseling and care is important.It is recommended that regular, long-term postoperative follow-up be undertaken to detect early signs of component wear or infection, and to consider the course of action to be taken if such events occur.A suitable rehabilitation program should be designed and implemented.¿infection is a clinically well known potential complication of any surgical procedure including knee arthroplasty.If infection occurs after knee replacement, whether related to the procedure or otherwise, the foreign metal and plastic implants can serve as a surface for the bacteria to latch onto, inaccessible to antibiotics.Even if the implants remain well fixed, the pain, swelling, and drainage from the infection make the revision surgery necessary.With current surgical techniques and antibiotic regimens, the rate of infection following total knee arthroplasty ranges from 0.4% to 2.5%.1 the highest risk period for infection is between six months and three years.2 based on review of all available information, there is no evidence to suggest that the reported event is related to any design or manufacturing issues.The cause of the infection and subsequent revision cannot be conclusively determined; however, it is most likely related to the patient¿s underlying condition or is nosocomial in nature.References 1.P.B.Voleti, k.D.Baldwin, and gwo-chin lee.¿use of static or articulating spacers for infection following total knee arthroplasty: a systematic literature review¿.The journal of bone and joint surgery.Sept 2013; 95-a: 1594-9.2.J.B.Meding, m.A.Ritter, k.E.Davis, and a.Farris."meeting increased demand for total knee replacement and follow-up: determining optimal follow-up".The bone and joint journal.Nov 2013; 95-b: 1484-9.¿ (g5) pma/510(k) number: k063569.(h6) evaluation codes: 1735, 2993.Section h11: *the following sections have corrected information: (b5) it was reported that 1 month postoperatively from a tka, the patient¿s tibial insert was revised due to infection.It was also reported the patient was stable upon leaving the operating room.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EQUINOXE
Type of Device
EQUINOXE REVERSE 38MM HUMERAL LINER +0
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
MDR Report Key9104146
MDR Text Key162987375
Report Number1038671-2019-00463
Device Sequence Number1
Product Code KWT
UDI-Device Identifier10885862086655
UDI-Public10885862086655
Combination Product (y/n)N
PMA/PMN Number
K063569
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/19/2023
Device Model Number320-38-00
Device Catalogue Number320-38-00
Was Device Available for Evaluation? Yes
Date Manufacturer Received03/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-